• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视单体HIV-1蛋白酶。特性表征及性能改进的重新设计。

Revisiting monomeric HIV-1 protease. Characterization and redesign for improved properties.

作者信息

Louis John M, Ishima Rieko, Nesheiwat Issa, Pannell Lewis K, Lynch Shannon M, Torchia Dennis A, Gronenborn Angela M

机构信息

Laboratory of Chemical Physics, National Institute Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Biol Chem. 2003 Feb 21;278(8):6085-92. doi: 10.1074/jbc.M209726200. Epub 2002 Dec 4.

DOI:10.1074/jbc.M209726200
PMID:12468541
Abstract

Interactions between the C-terminal interface residues (96-99) of the mature HIV-1 protease were shown to be essential for dimerization, whereas the N-terminal residues () and Arg(87) contribute to dimer stability (Ishima, R., Ghirlando, R., Tozser, J., Gronenborn, A. M., Torchia, D. A., and Louis, J. M. (2001) J. Biol. Chem. 276, 49110-49116). Here we show that the intramonomer interaction between the side chains of Asp(29) and Arg(87) influences dimerization significantly more than the intermonomer interaction between Asp(29) and Arg(8'). Several mutants, including T26A, destablize the dimer, exhibit a monomer fold, and are prone to aggregation. To alleviate this undesirable property, we designed proteins in which the N- and C-terminal regions can be linked intramolecularly by disulfide bonds. In particular, cysteine residues were introduced at positions 2 and 97 or 98. A procedure for the efficient preparation of intrachain-linked polypeptides is presented, and it is demonstrated that the Q2C/L97C variant exhibits a native-like single subunit fold. It is anticipated that monomeric proteases of this kind will aid in the discovery of novel inhibitors aimed at binding to the monomer at the dimerization interface. This extends the target area of current inhibitors, all of which bind across the active site formed by both subunits in the active dimer.

摘要

成熟HIV-1蛋白酶C末端界面残基(96 - 99)之间的相互作用被证明对二聚化至关重要,而N末端残基()和精氨酸(87)则有助于二聚体的稳定性(Ishima, R., Ghirlando, R., Tozser, J., Gronenborn, A. M., Torchia, D. A., and Louis, J. M. (2001) J. Biol. Chem. 276, 49110 - 49116)。在这里我们表明,天冬氨酸(29)和精氨酸(87)侧链之间的单体内部相互作用对二聚化的影响远大于天冬氨酸(29)和精氨酸(8')之间的单体间相互作用。包括T26A在内的几个突变体使二聚体不稳定,呈现单体构象,并且易于聚集。为了减轻这种不良特性,我们设计了可以通过二硫键在分子内连接N末端和C末端区域的蛋白质。特别是,在位置2和97或98引入了半胱氨酸残基。本文介绍了一种高效制备链内连接多肽的方法,并证明Q2C/L97C变体呈现出类似天然的单亚基构象。预计这类单体蛋白酶将有助于发现旨在在二聚化界面与单体结合的新型抑制剂。这扩展了当前抑制剂的作用靶点范围,目前所有抑制剂都是结合在活性二聚体中由两个亚基形成的活性位点上。

相似文献

1
Revisiting monomeric HIV-1 protease. Characterization and redesign for improved properties.重新审视单体HIV-1蛋白酶。特性表征及性能改进的重新设计。
J Biol Chem. 2003 Feb 21;278(8):6085-92. doi: 10.1074/jbc.M209726200. Epub 2002 Dec 4.
2
Folded monomer of HIV-1 protease.HIV-1蛋白酶的折叠单体
J Biol Chem. 2001 Dec 28;276(52):49110-6. doi: 10.1074/jbc.M108136200. Epub 2001 Oct 11.
3
Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor.
J Biol Chem. 2003 Oct 31;278(44):43311-9. doi: 10.1074/jbc.M307549200. Epub 2003 Aug 21.
4
Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease.揭示成熟 HIV-2 蛋白酶的二聚体解离和折叠单体的存在。
Protein Sci. 2009 Dec;18(12):2442-53. doi: 10.1002/pro.261.
5
Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.对HIV-1蛋白酶活性位点苏氨酸的系统性突变分析:重新审视“消防员握法”假说。
Protein Sci. 2000 Sep;9(9):1631-41. doi: 10.1110/ps.9.9.1631.
6
Autoprocessing of HIV-1 protease is tightly coupled to protein folding.HIV-1蛋白酶的自加工与蛋白质折叠紧密相关。
Nat Struct Biol. 1999 Sep;6(9):868-75. doi: 10.1038/12327.
7
Modulation of dimer stability in yeast pyrophosphatase by mutations at the subunit interface and ligand binding to the active site.通过亚基界面处的突变以及配体与活性位点的结合来调节酵母焦磷酸酶中二聚体的稳定性。
J Biol Chem. 2002 May 3;277(18):15465-71. doi: 10.1074/jbc.M200101200. Epub 2002 Feb 19.
8
Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.溶液核磁共振证据表明,在与不对称药物KNI-272形成的复合物中,HIV-1蛋白酶催化天冬氨酰基团具有不同的电离状态。
Biochemistry. 1996 Aug 6;35(31):9945-50. doi: 10.1021/bi961268z.
9
Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.人类免疫缺陷病毒1型蛋白酶与保守的CA-p2底物类似物的晶体学分析——与底物P2'位置常见谷氨酸残基的相互作用。
Eur J Biochem. 1997 Oct 15;249(2):523-30. doi: 10.1111/j.1432-1033.1997.00523.x.
10
Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.逆转录病毒蛋白酶二聚化的动力学:“消防员握法”与二聚化
Protein Sci. 2003 Oct;12(10):2173-82. doi: 10.1110/ps.03171903.

引用本文的文献

1
Evolution of drug resistance drives destabilization of flap region dynamics in HIV-1 protease.耐药性的演变推动了HIV-1蛋白酶中瓣区动力学的不稳定。
Biophys Rep (N Y). 2023 Aug 10;3(3):100121. doi: 10.1016/j.bpr.2023.100121. eCollection 2023 Sep 13.
2
Relative domain orientation of the L289K HIV-1 reverse transcriptase monomer.L289K HIV-1 逆转录酶单体的相对结构域取向。
Protein Sci. 2022 May;31(5):e4307. doi: 10.1002/pro.4307.
3
Diverse Folding Pathways of HIV-1 Protease Monomer on a Rugged Energy Landscape.HIV-1 蛋白酶单体在崎岖能量景观上的多种折叠途径。
Biophys J. 2019 Oct 15;117(8):1456-1466. doi: 10.1016/j.bpj.2019.09.015. Epub 2019 Sep 18.
4
Inhibition of human endogenous retrovirus-K by antiretroviral drugs.抗逆转录病毒药物对人类内源性逆转录病毒-K的抑制作用。
Retrovirology. 2017 Mar 22;14(1):21. doi: 10.1186/s12977-017-0347-4.
5
Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.临床抑制剂与合理选择的多药耐药HIV-1蛋白酶模型前体的结合明显弱于与释放的成熟酶的结合。
Biochemistry. 2016 Apr 26;55(16):2390-400. doi: 10.1021/acs.biochem.6b00012. Epub 2016 Apr 15.
6
Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.在药物压力下共同进化的自蛋白酶解位点和α-螺旋附近的突变调节HIV-1蛋白酶的自加工过程和活力。
Biochemistry. 2015 Sep 8;54(35):5414-24. doi: 10.1021/acs.biochem.5b00759. Epub 2015 Aug 21.
7
Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease.耐药性突变改变与抑制剂结合的HIV-1蛋白酶的动力学。
J Chem Theory Comput. 2014 Aug 12;10(8):3438-3448. doi: 10.1021/ct4010454. Epub 2014 Jun 12.
8
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir.HIV-1 蛋白酶的二聚作用通过两个步骤发生,这与达芦那韦抑制蛋白酶二聚作用的机制有关。
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12234-9. doi: 10.1073/pnas.1400027111. Epub 2014 Aug 4.
9
Investigation on the mechanism for the binding and drug resistance of wild type and mutations of G86 residue in HIV-1 protease complexed with Darunavir by molecular dynamic simulation and free energy calculation.基于分子动力学模拟和自由能计算研究野生型和 HIV-1 蛋白酶 G86 残基突变体与达芦那韦复合物的结合和耐药机制。
J Mol Model. 2014 Feb;20(2):2122. doi: 10.1007/s00894-014-2122-y. Epub 2014 Feb 14.
10
Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.单体折叠稳定性增强与 HIV-1 蛋白酶的极端耐药性相关。
Biochemistry. 2013 Oct 29;52(43):7678-88. doi: 10.1021/bi400962r. Epub 2013 Oct 15.